MetaADEDB 2.0 @ LMMD
Milnacipran
(XNCDYJFPRPDERF-PBCQUBLHSA-N)
Structure
SMILES
NC[C@H]1C[C@@]1(c1ccccc1)C(=O)N(CC)CC.Cl
Molecular Formula:
C15H23ClN2O
Molecular Weight:
282.809
Log P:
3.2737
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
46.33
CAS Number(s):
101152-94-7; 175131-61-0
Synonym(s)
1.
Milnacipran
2.
1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl
3.
F 2207
4.
F-2207
5.
Ixel
6.
Midalcipran
7.
Milnacipran Hydrochloride
8.
Savella
9.
1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl
10.
F2207
External Link(s)
MeSHD000078764
PubChem Compound55480
163701
ChEBI31854
CHEMBLCHEMBL1237129
KEGGdr:D01107
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 183US FAERS
2HeadacheFAERS: 99US FAERS
3DizzinessFAERS: 69US FAERS
4VomitingFAERS: 56US FAERS
5PainFAERS: 51US FAERS
6AnxietyFAERS: 45US FAERS
7Drug ineffectiveFAERS: 44US FAERS
8Feeling abnormalFAERS: 42US FAERS
9PalpitationsFAERS: 42US FAERS
10FatigueFAERS: 36US FAERS
11ConstipationFAERS: 30US FAERS
12TachycardiaFAERS: 29US FAERS
13AgitationFAERS: 25US FAERS
14TremorFAERS: 25US FAERS
15AngerFAERS: 21US FAERS
16AstheniaFAERS: 21US FAERS
17PruritusFAERS: 21US FAERS
18Urinary RetentionFAERS: 19US FAERS
19CryingFAERS: 18US FAERS
20FlushingFAERS: 18US FAERS
21MalaiseFAERS: 18US FAERS
22Abdominal PainFAERS: 17US FAERS
23Abdominal discomfortFAERS: 14US FAERS
24DysuriaFAERS: 14US FAERS
25HypersensitivityFAERS: 14US FAERS
26Chest PainFAERS: 13US FAERS
27UrticariaFAERS: 13US FAERS
28AlopeciaFAERS: 12US FAERS
29NervousnessFAERS: 11US FAERS
30SomnolenceFAERS: 11US FAERS
31Adverse eventFAERS: 10US FAERS
32AmnesiaFAERS: 10US FAERS
33Drug dose omissionFAERS: 10US FAERS
34Night sweatsFAERS: 10US FAERS
35ChillsFAERS: 9US FAERS
36Memory impairmentFAERS: 9US FAERS
37MyalgiaFAERS: 9US FAERS
38Serotonin SyndromeFAERS: 9US FAERS
39ArthralgiaFAERS: 8US FAERS
40Chest discomfortFAERS: 8US FAERS
41FibromyalgiaFAERS: 8US FAERS
42Myocardial InfarctionFAERS: 8US FAERS
43Suicide attemptFAERS: 8US FAERS
44Unevaluable eventFAERS: 8US FAERS
45Weight decreasedFAERS: 8US FAERS
46Mood swingsFAERS: 7US FAERS
47VertigoFAERS: 7US FAERS
48Atrial FibrillationFAERS: 6US FAERS
49DehydrationFAERS: 6US FAERS
50Feeling jitteryFAERS: 6US FAERS
51HypotensionFAERS: 6US FAERS
52Medication ErrorFAERS: 6US FAERS
53Oropharyngeal painFAERS: 6US FAERS
54SyncopeFAERS: 6US FAERS
55TinnitusFAERS: 6US FAERS
56AbasiaFAERS: 5US FAERS
57Activities of daily living impairedFAERS: 5US FAERS
58Emotional disorderFAERS: 5US FAERS
59Feeling ColdFAERS: 5US FAERS
60HostilityFAERS: 5US FAERS
61Hypertensive crisisFAERS: 5US FAERS
62Impaired work abilityFAERS: 5US FAERS
63Maternal exposure during pregnancyFAERS: 5US FAERS
64Musculoskeletal PainFAERS: 5US FAERS
65Neck PainFAERS: 5US FAERS
66RestlessnessFAERS: 5US FAERS
67RhabdomyolysisFAERS: 5US FAERS
68Wrong technique in product usage processFAERS: 5US FAERS
69Back PainFAERS: 4US FAERS
70Bipolar DisorderFAERS: 4US FAERS
71Blood glucose increasedFAERS: 4US FAERS
72Blood sodium decreasedFAERS: 4US FAERS
73Completed SuicideFAERS: 4US FAERS
74DiscomfortFAERS: 4US FAERS
75Drug withdrawal syndromeFAERS: 4US FAERS
76DyspepsiaFAERS: 4US FAERS
77ErythemaFAERS: 4US FAERS
78Food AllergyFAERS: 4US FAERS
79Musculoskeletal stiffnessFAERS: 4US FAERS
80Renal painFAERS: 4US FAERS
81Sexual DysfunctionFAERS: 4US FAERS
82Urinary hesitationFAERS: 4US FAERS
83Visual ImpairmentFAERS: 4US FAERS
84AphasiaFAERS: 3US FAERS
85Cerebrovascular accidentFAERS: 3US FAERS
86Depressed moodFAERS: 3US FAERS
87Erectile dysfunctionFAERS: 3US FAERS
88HypersomniaFAERS: 3US FAERS
89HypomaniaFAERS: 3US FAERS
90Impaired driving abilityFAERS: 3US FAERS
91Lip swellingFAERS: 3US FAERS
92Middle insomniaFAERS: 3US FAERS
93MydriasisFAERS: 3US FAERS
94ParanoiaFAERS: 3US FAERS
95Product dose omissionFAERS: 3US FAERS
96RetchingFAERS: 3US FAERS
97SwellingFAERS: 3US FAERS
98TensionFAERS: 3US FAERS
99Urinary IncontinenceFAERS: 3US FAERS
100Urinary tract infectionFAERS: 3US FAERS
101AcneFAERS: 2US FAERS
102Alanine Aminotransferase IncreasedFAERS: 2US FAERS
103Anaphylactic shockFAERS: 2US FAERS
104AngioedemaFAERS: 2US FAERS
105AnuriaFAERS: 2US FAERS
106AphagiaFAERS: 2US FAERS
107BlindnessFAERS: 2US FAERS
108Blood urine presentFAERS: 2US FAERS
109Burning sensationFAERS: 2US FAERS
110Cardiac FlutterFAERS: 2US FAERS
111ChromaturiaFAERS: 2US FAERS
112ClumsinessFAERS: 2US FAERS
113Cold sweatFAERS: 2US FAERS
114Drug screen positiveFAERS: 2US FAERS
115DysgeusiaFAERS: 2US FAERS
116Emotional distressFAERS: 2US FAERS
117Euphoric moodFAERS: 2US FAERS
118FlatulenceFAERS: 2US FAERS
119FrustrationFAERS: 2US FAERS
120HypothyroidismFAERS: 2US FAERS
121Impaired gastric emptyingFAERS: 2US FAERS
122Incorrect dose administeredFAERS: 2US FAERS
123InfluenzaFAERS: 2US FAERS
124Initial insomniaFAERS: 2US FAERS
125Intentional product misuseFAERS: 2US FAERS
126Intentional self-injuryFAERS: 2US FAERS
127Mental status changesFAERS: 2US FAERS
128Muscle tightnessFAERS: 2US FAERS
129NasopharyngitisFAERS: 2US FAERS
130PancreatitisFAERS: 2US FAERS
131PericarditisFAERS: 2US FAERS
132Personality ChangeFAERS: 2US FAERS
133PiloerectionFAERS: 2US FAERS
134Product packaging issueFAERS: 2US FAERS
135Product quality issueFAERS: 2US FAERS
136Prostatic painFAERS: 2US FAERS
137Quality of life decreasedFAERS: 2US FAERS
138Restless Legs SyndromeFAERS: 2US FAERS
139SerositisFAERS: 2US FAERS
140SomnambulismFAERS: 2US FAERS
141Status AsthmaticusFAERS: 2US FAERS
142Stevens-Johnson SyndromeFAERS: 2US FAERS
143StressFAERS: 2US FAERS
144Tension HeadacheFAERS: 2US FAERS
145Thermal burnFAERS: 2US FAERS
146Urine flow decreasedFAERS: 2US FAERS
147Wheelchair userFAERS: 2US FAERS
148White blood cell count decreasedFAERS: 2US FAERS
149Acute Coronary SyndromeFAERS: 1US FAERS
150AkathisiaFAERS: 1US FAERS
151Alcohol poisoningFAERS: 1US FAERS
152Altered visual depth perceptionFAERS: 1US FAERS
153Angina PectorisFAERS: 1US FAERS
154Angle Closure GlaucomaFAERS: 1US FAERS
155AnhedoniaFAERS: 1US FAERS
156Ankle FractureFAERS: 1US FAERS
157AnorgasmiaFAERS: 1US FAERS
158ApathyFAERS: 1US FAERS
159AphoniaFAERS: 1US FAERS
160Apparent deathFAERS: 1US FAERS
161ArthritisFAERS: 1US FAERS
162Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
163AtaxiaFAERS: 1US FAERS
164Atrial tachycardiaFAERS: 1US FAERS
165Auricular swellingFAERS: 1US FAERS
166BedriddenFAERS: 1US FAERS
167Benign Prostatic HyperplasiaFAERS: 1US FAERS
168Bladder spasmFAERS: 1US FAERS
169Blood PressureFAERS: 1US FAERS
170Blood alkaline phosphatase increasedFAERS: 1US FAERS
171Blood blisterFAERS: 1US FAERS
172Blood glucose decreasedFAERS: 1US FAERS
173Blood glucose fluctuationFAERS: 1US FAERS
174Blood pressure fluctuationFAERS: 1US FAERS
175Blood pressure inadequately controlledFAERS: 1US FAERS
176Bone painFAERS: 1US FAERS
177BradycardiaFAERS: 1US FAERS
178Breast tendernessFAERS: 1US FAERS
179Burning feet syndromeFAERS: 1US FAERS
180Capillary FragilityFAERS: 1US FAERS
181CardiomegalyFAERS: 1US FAERS
182CataractFAERS: 1US FAERS
183Catheter site dischargeFAERS: 1US FAERS
184Choking sensationFAERS: 1US FAERS
185Compulsive shoppingFAERS: 1US FAERS
186Creatinine renal clearance decreasedFAERS: 1US FAERS
187Creatinine renal clearance increasedFAERS: 1US FAERS
188CyanosisFAERS: 1US FAERS
189CystitisFAERS: 1US FAERS
190DeliriumFAERS: 1US FAERS
191Dental cariesFAERS: 1US FAERS
192Diabetes MellitusFAERS: 1US FAERS
193DisorientationFAERS: 1US FAERS
194DissociationFAERS: 1US FAERS
195Drug dose titration not performedFAERS: 1US FAERS
196Drug ineffective for unapproved indicationFAERS: 1US FAERS
197Drug toxicityFAERS: 1US FAERS
198Dry skinFAERS: 1US FAERS
199DysphoniaFAERS: 1US FAERS
200DystoniaFAERS: 1US FAERS
201Ear discomfortFAERS: 1US FAERS
202Economic problemFAERS: 1US FAERS
203EczemaFAERS: 1US FAERS
204EosinophiliaFAERS: 1US FAERS
205EpistaxisFAERS: 1US FAERS
206EructationFAERS: 1US FAERS
207Erythema MultiformeFAERS: 1US FAERS
208Erythema NodosumFAERS: 1US FAERS
209Expired product administeredFAERS: 1US FAERS
210Eye irritationFAERS: 1US FAERS
211Eye painFAERS: 1US FAERS
212False negative pregnancy testFAERS: 1US FAERS
213FasciitisFAERS: 1US FAERS
214Food PoisoningFAERS: 1US FAERS
215FormicationFAERS: 1US FAERS
216GastritisFAERS: 1US FAERS
217Gastrointestinal infectionFAERS: 1US FAERS
218Gastrointestinal motility disorderFAERS: 1US FAERS
219General physical health deteriorationFAERS: 1US FAERS
220Gingival RecessionFAERS: 1US FAERS
221GlaucomaFAERS: 1US FAERS
222Gluten sensitivityFAERS: 1US FAERS
223Head discomfortFAERS: 1US FAERS
224Hepatic congestionFAERS: 1US FAERS
225HepatotoxicityFAERS: 1US FAERS
226Hormone level abnormalFAERS: 1US FAERS
227HyperreflexiaFAERS: 1US FAERS
228HypervigilanceFAERS: 1US FAERS
229HypophagiaFAERS: 1US FAERS
230Hypotonic urinary bladderFAERS: 1US FAERS
231IleusFAERS: 1US FAERS
232Inappropriate schedule of drug administrationFAERS: 1US FAERS
233IncoherentFAERS: 1US FAERS
234Intentional product use issueFAERS: 1US FAERS
235Irritable Bowel SyndromeFAERS: 1US FAERS
236Lack of spontaneous speechFAERS: 1US FAERS
237LagophthalmosFAERS: 1US FAERS
238LethargyFAERS: 1US FAERS
239Loss of personal independence in daily activitiesFAERS: 1US FAERS
240Lupus-like syndromeFAERS: 1US FAERS
241LymphadenopathyFAERS: 1US FAERS
242MeningitisFAERS: 1US FAERS
243MenorrhagiaFAERS: 1US FAERS
244Mental impairmentFAERS: 1US FAERS
245MicropenisFAERS: 1US FAERS
246Milk soy protein intoleranceFAERS: 1US FAERS
247Morbid thoughtsFAERS: 1US FAERS
248Motion SicknessFAERS: 1US FAERS
249Multiple allergiesFAERS: 1US FAERS
250Multiple drug overdose intentionalFAERS: 1US FAERS
251Muscle RigidityFAERS: 1US FAERS
252Musculoskeletal discomfortFAERS: 1US FAERS
253MyocarditisFAERS: 1US FAERS
254MyoclonusFAERS: 1US FAERS
255MyopiaFAERS: 1US FAERS
256NarcolepsyFAERS: 1US FAERS
257NephrolithiasisFAERS: 1US FAERS
258Neuroleptic Malignant SyndromeFAERS: 1US FAERS
259No adverse eventFAERS: 1US FAERS
260Ophthalmological examination abnormalFAERS: 1US FAERS
261Pain of skinFAERS: 1US FAERS
262Painful ejaculationFAERS: 1US FAERS
263Pelvic PainFAERS: 1US FAERS
264Peptic UlcerFAERS: 1US FAERS
265Peripheral swellingFAERS: 1US FAERS
266Physical assaultFAERS: 1US FAERS
267PneumoniaFAERS: 1US FAERS
268Product formulation issueFAERS: 1US FAERS
269Product label issueFAERS: 1US FAERS
270Product substitution issueFAERS: 1US FAERS
271Product use issueFAERS: 1US FAERS
272Psychiatric symptomFAERS: 1US FAERS
273Pulmonary EmbolismFAERS: 1US FAERS
274PyelonephritisFAERS: 1US FAERS
275Rash erythematousFAERS: 1US FAERS
276Respiratory distressFAERS: 1US FAERS
277ScreamingFAERS: 1US FAERS
278SepsisFAERS: 1US FAERS
279ShopliftingFAERS: 1US FAERS
280Sinus TachycardiaFAERS: 1US FAERS
281Skin irritationFAERS: 1US FAERS
282Sleep TalkingFAERS: 1US FAERS
283TachyarrhythmiaFAERS: 1US FAERS
284Tardive DyskinesiaFAERS: 1US FAERS
285Temperature regulation disorderFAERS: 1US FAERS
286TenosynovitisFAERS: 1US FAERS
287Therapeutic response unexpectedFAERS: 1US FAERS
288Therapy cessationFAERS: 1US FAERS
289Therapy changeFAERS: 1US FAERS
290ThirstFAERS: 1US FAERS
291Throat irritationFAERS: 1US FAERS
292ThrombosisFAERS: 1US FAERS
293Tooth ErosionFAERS: 1US FAERS
294Tooth ExtractionFAERS: 1US FAERS
295Tooth LossFAERS: 1US FAERS
296ToothacheFAERS: 1US FAERS
297Vascular ruptureFAERS: 1US FAERS
298WheezingFAERS: 1US FAERS
299Wrong drug administeredFAERS: 1US FAERS
300prostatitisFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.